Requests for drug analysis accounted for nearly half of all requests (DNA, toxicology, latent prints, etc.) submitted to forensic laboratories in the United States (Storm et al., 2010). A study by RTI International found that laboratories are only capable of processing about 80% of their controlled substances requests. Based upon this statistic, an estimated 220,000 cases per year would be back-logged. Therefore, tools that can improve the process of seized drug analysis would be of use. This project addresses one such concept, the use of retention indices as a means to improve drug screening using gas chromatography/mass spectrometry (GC/MS). When drugs that co-elute (such as methamphetamine and phentermine) are analyzed, a mass spectrum would not be useful as both substances will give similar spectra. This presents problems especially with designer drugs that are similar in structure and molecular weight. Retention index, when coupled with mass spectrometry, can differentiate drugs that co-elute, thus reducing false positives and improving screening processes and the reliability of identification of compounds with similar mass spectra.